Sagittarius Life Science Corp (3205.TWO)
TWD 27.55
(-9.97%)
TWD 27.55
(-9.97%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -44.73 Million TWD | 24.64% |
| 2022 | -55.4 Million TWD | 12.0% |
| 2021 | -65.92 Million TWD | -32.03% |
| 2020 | -50.66 Million TWD | 47.08% |
| 2019 | -83.66 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -9.24 Million TWD | 59.86% |
| 2024 Q2 | -12.85 Million TWD | -105.09% |
| 2023 Q3 | -7.69 Million TWD | 0.62% |
| 2023 Q2 | -7.74 Million TWD | 27.42% |
| 2023 Q4 | -15.61 Million TWD | -102.94% |
| 2023 FY | - TWD | 24.64% |
| 2023 Q1 | -10.66 Million TWD | 40.46% |
| 2022 Q4 | -17.91 Million TWD | 0.0% |
| 2022 FY | - TWD | 12.0% |
| 2021 FY | - TWD | -32.03% |
| 2020 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 3.254% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 111.366% |
| Level Biotechnology Inc. | 98.7 Million TWD | 145.326% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 37.962% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -77.304% |
| GlycoNex Incorporation | -126.82 Million TWD | 64.724% |
| VBI | -6.97 Million TWD | -541.695% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 68.865% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 305.131% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -152.392% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 56.822% |
| Visgeneer Inc. | 973 Thousand TWD | 4698.047% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 86.821% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 104.777% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 144.812% |
| Neith Corporation | -33.61 Million TWD | -33.112% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 95.486% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -2475.648% |
| Enimmune corporation | -228.96 Million TWD | 80.46% |
| TaiRx, Inc. | -208.64 Million TWD | 78.557% |
| CHO Pharma, Inc. | -277.73 Million TWD | 83.891% |
| EirGenix Inc. | -664.4 Million TWD | 93.266% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 160.537% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 164.705% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 95.824% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 60.445% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 228.42% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 28.235% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -70.11% |
| RBC Bioscience Corporation | 36.54 Million TWD | 222.415% |
| BiOptic Inc. | 65.03 Million TWD | 168.789% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 93.444% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -35.548% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 18.53% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 110.319% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 44.127% |
| NaviFUS Corp. | -55.79 Million TWD | 19.815% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -169.545% |
| Sinew Pharma Inc. | -163.63 Million TWD | 72.659% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 27.254% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 123.253% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 80.263% |
| AP Biosciences Inc | -325.51 Million TWD | 86.256% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 95.717% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -24.809% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 253.584% |
| Intech Biopharm Corporation | -219.58 Million TWD | 79.626% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 93.364% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 0.472% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 72.187% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 106.825% |
| TCI GENE Inc. | 25.98 Million TWD | 272.199% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 59.563% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 84.235% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 69.351% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 423.025% |
| PharmaEngine, Inc. | 347.3 Million TWD | 112.882% |
| Savior Lifetec Corporation | 219.6 Million TWD | 120.372% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 125.976% |
| OBI Pharma, Inc. | -855.08 Million TWD | 94.768% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 51.666% |
| Acepodia, Inc. | -764.51 Million TWD | 94.148% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 90.276% |